Haemonetics Corporation (HAE) by event type
HAE moves most on analyst downgrades — a median of -0.39% at 30 minutes across 20 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the HAE overview →
How HAE reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 765 of 2,717 | 22 | +0.22% | 55% | -0.13% |
| Analyst downgrades 2,114 of 2,603 | 20 | -0.39% | 50% | -2.07% |
| Coverage initiations 1,835 of 2,283 | 18 | -0.39% | 22% | +0.38% |
| Rating reiterations 2,271 of 3,522 | 91 | -0.05% | 43% | -0.26% |
| Price-target raises 551 of 1,790 | 16 | +0.07% | 56% | +0.94% |
| Price-target cuts 769 of 1,527 | 14 | -0.01% | 50% | -0.98% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how HAE usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · HAE overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| iBio, Inc. (IBIO) | 263 | -0.38% | 43% |
| NOVUS THERAPEUTICS (NVUS) | 263 | -0.14% | 40% |
| Avanos Medical, Inc. (AVNS) | 259 | 0.00% | 45% |
| Enanta Pharmaceuticals, Inc. (ENTA) | 257 | +0.06% | 50% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.